[1] 葛小金,于挺敏. 脑出血早期血肿扩大危险因素的临床研究[J].中风与神经疾病杂志, 2018,35(1):44-47.
[2] Landreneau MJ,Mullen MT,Messé SR, et al.CCL 2 and CXCL 10 are associated with poor outcome after intracerebral hemorrhage[J].Ann Clin Transl Neurol,2018,5(8):962-970.
[3] 中华人民共和国卫生部.中华人民共和国卫生行业标准:成人自发性脑出血诊断标准[M].北京:人民卫生出版社,2010:3-4.
[4] Carmichael ST, Vespa PM, Saver JL, et al. Genomic profiles of damage and protection in human intracerebral hemorrhage[J]. J Cereb Blood Flow Metab, 2008,28(11):1860-1875.
[5] 施栋梁,林青.趋化因子CXCL9、CXCL10、CXCL11与狼疮肾炎相关性研究进展[J].免疫学杂志,2016,32(7):630-633.
[6] 刘辉,高峻.肝脏肿瘤射频消融术围术期血清CXCL10和CXCL12水平的变化及其临床意义[J].实验与检验医学,2017,35(5):684-686.
[7] 贺树成,李运曼,方伟蓉.CCR2/CCL2对脑缺血再灌注损伤影响的研究进展[J]. 药学与临床研究, 2018,26(3):196-201.
[8] Amin M, Vakilian A, Mahmoodi MH, et al. Circulatory levels of C-X-C motif chemokine ligands 1, 9, and 10 are elevated in patients with ischemic stroke[J]. Eurasian J Med, 2017,49(2):92-96. |
2019, Vol. 36 
